Articles Tagged With:
-
Pregnancy with IUDs in Place: What Is the Risk of Complications?
In this retrospective cohort study, 233 individuals who conceived with a copper intrauterine device (IUD) in place were followed. There were 44 ectopic pregnancies, 31 non-viable intrauterine pregnancies, and 158 viable intrauterine pregnancies. Of the viable pregnancies, 137 patients continued the pregnancy and, of these, 54 had the IUD removed. Those who underwent IUD removal had a lower rate of pregnancy loss (33%) compared to those who retained the IUD (61.4%).
-
Does Treatment of Gestational Diabetes Before 20 Weeks of Gestation Improve Pregnancy Outcomes?
Therapy for gestational diabetes diagnosed before 20 weeks of pregnancy was associated with a slightly decreased frequency of a composite of unfavorable neonatal outcomes compared to deferred treatment or no therapy. No significant changes were demonstrated for pregnancy-related hypertension or neonatal lean body mass between the two groups.
-
Risk-Reducing Surgery and Quality of Life for Patients with Breast and Ovarian Cancer
Risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) for patients at high risk of breast and ovarian cancer led to decreased cancer-related distress, unaffected health-related quality of life, poorer body image after RRM, and decreased sexual function and increased menopause symptoms after RRSO.
-
Patients Desire Telemedicine for Abortion Care
New research confirms previous studies in demonstrating the safety and efficacy of medication abortion pills. Studies also show there is strong desire for this option among people seeking an end to their pregnancy.
-
Nonhormonal Treatment for Menopausal Vasomotor Symptoms: A Phase III Study of Fezolinetant
In this multinational, randomized, double blind, placebo-controlled trial, 522 women with moderate to severe menopausal vasomotor symptoms received either 45 mg of fezolinetant, 30 mg fezolinetant, or placebo. Both fezolinetant doses significantly reduced the frequency and severity of menopausal symptoms at four and 12 weeks of treatment as compared with placebo.
-
It May Be Ethical for Providers to Refuse to Comply with Abortion Laws
What should providers do when state law conflicts with their ethical duty to preserve the health and life of a patient? Each provider and healthcare organization has been left to interpret their states’ laws with little guidance and precedence. Some hospitals are sued for not providing care when a pregnant patient’s life was in danger. In other cases, physicians are required to visit their employer’s legal office for permission to save patients’ health and lives. The authors of a new paper defend physician noncompliance with anti-abortion legislation, arguing physicians’ obligations to comply with the law are defeated when the law is illegitimate.
-
Study Finds Increased Risk of Depression with Use of Oral Contraceptives
A population-based cohort study with data for more than 260,000 women revealed oral contraception use can increase the risk of depression, particularly during the first two years of its use. For adolescents, its use can increase later-in-life risk of depression, as well. Investigators said their results were consistent with a causal relationship between oral contraceptive use and depression.
-
People Can Safely Self-Manage Medication Abortion After 10 Weeks
Abortion care for women in their late first trimester and second trimester of pregnancy has been abolished in some states — even when the patient’s health or life is at risk during a miscarriage or other pregnancy crisis. As increasing numbers of people turn to self-managed abortion for ending their pregnancies, this option has not been seen as an alternative for U.S. women who are more than 10 weeks pregnant — until now.
-
What Is Next for the First OTC Birth Control Pill Approved by the FDA?
It took contraceptive care advocates more than two decades, but they achieved success on July 13, when the U.S. Food and Drug Administration approved Opill, the first over-the-counter hormonal birth control pill, for use in the United States.
-
Caregivers of Foster Youth Play Role in Contraceptive Decisions
Foster youth are vulnerable and at high risk of pregnancy. Reproductive health providers need to work with the youth and their caregivers to build a trusting relationship when discussing contraception.